ADPT Adaptive Biotechnologies Corp
Company Analysis
Latest News
🟢 Adaptive Biotechnologies is trading 6.9% up today in after-hours trading without a clear news catalyst
Adaptive Biotechnologies is trading 6.9% up at $23.80 in after-hours trading, compared with a regular-session close of $22.27, despite a lack of specific...
🔴 Adaptive Biotechnologies is trading 4.16% down today on profit-taking and broader biotech sector weakness
Adaptive Biotechnologies is trading at $20.95 (-4.16%) following a sharp pullback from a recent rally that pushed the stock toward 52-week highs. • The...
🔴 Adaptive Biotechnologies is trading 4.3% down today on profit-taking after a multi-day rally
Adaptive Biotechnologies is trading 4.3% down at $21.94 on profit-taking following a sharp multi-day rally that recently pushed shares near 52-week highs. •...
🟢 Adaptive Biotechnologies is trading 4.7% up today, extending momentum after hitting a new 52-week high
Adaptive Biotechnologies is trading at $24.00 (4.7% up) in pre-market, extending a strong multi-day uptrend that recently saw the stock surpass its previous...
🔴 Adaptive Biotechnologies Corp is trading 4.10% down
ADPT is trading at $21.96, down 4.10%.
🔴 Adaptive Biotechnologies is trading 5% down today as investors consolidate gains following its $300 million debt offering rally
Adaptive Biotechnologies is trading at $20.00, down 5% in after-hours as investors consolidate gains following a sharp rally driven by strategic business...
🔴 Adaptive Biotechnologies is trading 4.2% down today as investors consolidate gains after post-offering rally
Adaptive Biotechnologies is trading 4.2% down at $20.89 as investors consolidate gains following a sharp rally driven by its $300 million convertible notes...
🟢 Adaptive Biotechnologies Surges 6.05% Following Analyst Price Target Increase and Reiterated 'Buy' Rating
Adaptive Biotechnologies is trading at $21.38 (+6.05%) today, following a positive analyst update. • The company's 12-month average price target was raised to...
🔴 ADPT is trading 4.5% down today amid broader market weakness
ADPT is trading at $19.89, down 4.5% today, as the stock faces pressure from a weak broader market backdrop and macro volatility. • Major indices are all...
🔴 ADPT extends move to 5.3% down
ADPT is trading at $21.18, down 5.3% versus the comparison close of $22.37 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ADPT is trading 4.15% up today as it extends a multi-day rally on pipeline optimism
ADPT is trading 4.15% up at $22.34 as it extends a sharp multi-day rally driven by growing investor confidence in its clonoSEQ platform and broader...
🟢 ADPT is trading 4.4% up today, extending a multi-day rally amid a positive market backdrop
ADPT is trading at $21.88 (4.4% up) in pre-market, extending a sharp multi-day rally driven by sustained investor momentum and a broadly positive market...
🟢 ADPT surges 5.1% today fueled by business separation plans and recent convertible notes offering
ADPT is trading 5.1% up at $20.33 today. • This follows the company's recent announcement on June 15, 2026, of its plan to separate the Minimal Residual...
🟢 ADPT makes sharp 10.5% jump
ADPT is trading at $19.04, up 10.5% versus the comparison close of $17.23 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ADPT extends move to 6.9% up
ADPT is trading at $18.42, up 6.9% versus the comparison close of $17.23 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ADPT is trading 5% up today, rebounding from recent financing-related weakness
ADPT is trading about 5% up today at $18.09, rebounding from recent weakness despite no fresh company-specific headlines this morning. • The move appears...
Adaptive Biotechnologies Closes $345M Convertible Note Offering, Repays OrbiMed Agreement
Adaptive Biotechnologies announced the issuance of $345 million in 0% Convertible Senior Notes due 2031, including the full exercise of a $45 million option by...
🔴 Adaptive Biotechnologies Corp is trading 4.3% down today on dilution concerns from $300M convertible notes and restructuring
Adaptive Biotechnologies Corp is trading 4.3% down at $16.48 today as investors weigh the impact of an upsized $300 million convertible notes offering and a...
🟢 Adaptive Biotechnologies Corp is trading 4.8% up today as it rebounds from a sharp drop following restructuring and upsized financing news
• The company announced a strategic split between its MRD cancer-testing diagnostics business and its Immune Medicine drug-discovery arm to optimize its...
🔴 Adaptive Biotechnologies Corp is trading 4.4% down today on business split and $250M convertible notes offering
Adaptive Biotechnologies Corp is trading 4.4% down at $16.69 today after announcing a major business restructuring and a $250 million private financing...